Bringing BioPharma Products to Market

Meeting Request
EXECUTIVE MANAGEMENT CONSULTING AGENCY

BIOPHARMA QUALITY ASSURANCE

Experienced leadership to navigate regulatory compliance for new product development.

Read More

WE BRING BIOPHARMA PRODUCTS TO MARKET​

Achieving product approval and commercialization requires a focus on meeting the needs of a biotech license submission and strong quality management.

We Help You Navigate Regulatory Requirements

BioQPartners has the experience and expertise to help you navigate this path quickly and effectively. We have helped clients with development strategy from the early preclinical stages, through submission, PAI preparation and approval, and into efficient commercial operations.

Schedule A Meeting
biopharmaceutical products to market

Your Competitive Advantage
Is Our Proven Track Record.

Our experience and expertise bringing 100+ biopharmaceutical products to market is ready to help you with:

Achieving your goal of product approval and commercialization requires a focus on meeting all the needs of a license submission and strong quality management. Let our experience work for you. 
Schedule A Meeting

The best guide comes from our experience

In the rapidly-evolving world of gene therapy, cell therapy and complex recombinant proteins, the best guidance for successful licensure and commercialization comes from experience.

bioqpartners mission is to bring

Novel Therapies

to market quickly and efficiently
Learn More

Testimonials

“As a leader, Mark truly cares about his people. He is knowledgeable on just about everything, and can discuss and strategize on any topic.”
—Senior VP
at a Biopharmaceutical Firm
“Mark sees life through a different lens. He treats everyone with incredible empathy, and is very respectful of other people’s time. This allows him to be very efficient at understanding what his client’s need and delivering it promptly.”
—Senior Director
at a Gene Therapy Firm
“Mark is very fun to work with. He’s great at understanding the “why,” which is very important in novel therapeutics. He is able to break things down to the first principle level, and that allows him to effectively provide solutions. As complicated and difficult as some of these projects can be, you know it will always be fun with Mark.”
—Industry Peer
Biotech Executive

Numbers Speak

Offices
1
Employees
1 K
Clients
1
Countries
1